SA PRO
Free Account
PMV Pharmaceuticals, Inc.PMVPNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
4 analysts·Low coverage
100%
Rating Distribution
Strong Buy
00%
Buy
4100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 1567% higher.

Bear Case
$5.00
+363%
Consensus
$18.00
+1567%
Bull Case
$36.00
+3233%
Price Range4 analysts
Low
Consensus
High
$5.00
$36.00
Current Target
Current Price
$1.08
Upside to Target
$16.92

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Nov 8, 2024Oppenheimer
Oppenheimer Upgrades PMV Pharmaceuticals Inc. (PMVP) to Outperform
Target:$6.00
+243.8%from $1.75
Apr 11, 2024Jefferies
PMV Pharmaceuticals initiated with a Buy at Jefferies
Target:$5.00
+216.5%from $1.58
Nov 17, 2022H.C. Wainwright
HC Wainwright & Co. Maintains Buy on PMV Pharma, Lowers Price Target to $36
Target:$36.00
+249.9%from $10.29
Jun 9, 2022Oppenheimer
Oppenheimer Maintains Outperform on PMV Pharma, Raises Price Target to $33
Target:$33.00
+222.3%from $10.24
May 24, 2022Goldman Sachs
Goldman Sachs Maintains Buy on PMV Pharma, Lowers Price Target to $25
Target:$25.00
+77.4%from $14.09

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance